GLADSTONE INVESTMENT CORPORATIONDE
GAINAnalytical Summary
GLADSTONE INVESTMENT CORPORATIONDE shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.
28-Year Financial Trajectory
QuarterlyBullish Indicators
- Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
Bearish Risks
- No bearish risks detected.
Health Breakdown
Dividend History
Dividend / share · sourced from SEC filingsStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Sep 30, 2023 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Dec 31, 2022 10-Q ↗ | Q2 FY2023 Sep 30, 2022 10-Q ↗ | Q1 FY2023 Jun 30, 2022 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Dec 31, 2021 10-Q ↗ | Q2 FY2022 Sep 30, 2021 10-Q ↗ | Q1 FY2022 Apr 30, 2021 10-Q ↗ | Q4 FY2021 Apr 30, 2021 10-K ↗ | Q4 FY2020 Apr 30, 2020 10-K ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q4 FY2018 Mar 31, 2018 10-K ↗ | Q4 FY2017 Mar 31, 2017 10-K ↗ | Q4 FY2016 Mar 31, 2016 10-K ↗ | Q4 FY2015 Mar 31, 2015 10-K ↗ | Q4 FY2014 Mar 31, 2014 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) | — | — | — | — | — |
-89.3%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
36.0%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-51.7%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
7.7%
Fair
↓
Fair
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
13.6%
Fair
↓
Fair
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
45.0%
Excellent
↓
Excellent
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
4.0%
Caution
Caution
Year-over-year change in earnings per share
Optimal:
> 10%
|
385.7%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income Growth YoY (%) |
360.9%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
71.2%
Excellent
Excellent
Year-over-year change in net income |
85.4%
Excellent
Excellent
Year-over-year change in net income |
N/M | — |
485.0%
Excellent
Excellent
Year-over-year change in net income |
-67.3%
Weak
Weak
Year-over-year change in net income |
N/M | — |
-58.3%
Weak
↓
Weak
Declining
Year-over-year change in net income |
1440.0%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-27.0%
Weak
↑
Weak
Improving
Year-over-year change in net income |
-72.1%
Weak
↓
Weak
Declining
Year-over-year change in net income |
52.5%
Excellent
Excellent
Year-over-year change in net income |
-89.1%
Weak
Weak
Year-over-year change in net income |
— | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS CAGR 3Y (%) | — | — | — | — | — |
-50.7%
Weak
Weak
Compound annual EPS growth over 3 years |
41.9%
Excellent
Excellent
Compound annual EPS growth over 3 years |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Sep 30, 2023 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Dec 31, 2022 10-Q ↗ | Q2 FY2023 Sep 30, 2022 10-Q ↗ | Q1 FY2023 Jun 30, 2022 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Dec 31, 2021 10-Q ↗ | Q2 FY2022 Sep 30, 2021 10-Q ↗ | Q1 FY2022 Apr 30, 2021 10-Q ↗ | Q4 FY2021 Apr 30, 2021 10-K ↗ | Q4 FY2020 Apr 30, 2020 10-K ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q4 FY2018 Mar 31, 2018 10-K ↗ | Q4 FY2017 Mar 31, 2017 10-K ↗ | Q4 FY2016 Mar 31, 2016 10-K ↗ | Q4 FY2015 Mar 31, 2015 10-K ↗ | Q4 FY2014 Mar 31, 2014 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
0.20x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.12x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.11x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-6.46x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
6.30x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
-1.89x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — |
-4.15x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.91x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.25x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-16.51x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
3.43x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.16x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
4.41x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — | — | — | — | — | — | — |
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Sep 30, 2023 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Dec 31, 2022 10-Q ↗ | Q2 FY2023 Sep 30, 2022 10-Q ↗ | Q1 FY2023 Jun 30, 2022 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Dec 31, 2021 10-Q ↗ | Q2 FY2022 Sep 30, 2021 10-Q ↗ | Q1 FY2022 Apr 30, 2021 10-Q ↗ | Q4 FY2021 Apr 30, 2021 10-K ↗ | Q4 FY2020 Apr 30, 2020 10-K ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q4 FY2018 Mar 31, 2018 10-K ↗ | Q4 FY2017 Mar 31, 2017 10-K ↗ | Q4 FY2016 Mar 31, 2016 10-K ↗ | Q4 FY2015 Mar 31, 2015 10-K ↗ | Q4 FY2014 Mar 31, 2014 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
12.3%
Fair
↑
Fair
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
11.1%
Fair
↑
Fair
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
5.4%
Caution
↑
Caution
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.6%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.6%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
7.9%
Caution
↑
Caution
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.4%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-1.4%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— |
1.4%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
10.0%
Caution
↑
Caution
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.0%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.1%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.5%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
0.7%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.7%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.7%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.3%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
6.4%
Caution
Caution
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — | — | — | — | — | — | — |
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Sep 30, 2023 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Dec 31, 2022 10-Q ↗ | Q2 FY2023 Sep 30, 2022 10-Q ↗ | Q1 FY2023 Jun 30, 2022 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Dec 31, 2021 10-Q ↗ | Q2 FY2022 Sep 30, 2021 10-Q ↗ | Q1 FY2022 Apr 30, 2021 10-Q ↗ | Q4 FY2021 Apr 30, 2021 10-K ↗ | Q4 FY2020 Apr 30, 2020 10-K ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q4 FY2018 Mar 31, 2018 10-K ↗ | Q4 FY2017 Mar 31, 2017 10-K ↗ | Q4 FY2016 Mar 31, 2016 10-K ↗ | Q4 FY2015 Mar 31, 2015 10-K ↗ | Q4 FY2014 Mar 31, 2014 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) |
0.84x
Fair
↓
Fair
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.96x
Fair
→
Fair
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.04x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.07x
Caution
↑
Caution
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.91x
Fair
→
Fair
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.12x
Caution
↑
Caution
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.74x
Fair
↓
Fair
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.83x
Fair
→
Fair
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.81x
Fair
↓
Fair
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.90x
Fair
→
Fair
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.86x
Fair
Fair
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
0.86x
Fair
Fair
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt (USD) | $564.47M | $571.84M | $555.03M | $514.51M | $455.71M | $543.99M | $339.01M | $392.94M | $395.88M | $410.69M | $407.58M | $339.06M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Sep 30, 2023 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Dec 31, 2022 10-Q ↗ | Q2 FY2023 Sep 30, 2022 10-Q ↗ | Q1 FY2023 Jun 30, 2022 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Dec 31, 2021 10-Q ↗ | Q2 FY2022 Sep 30, 2021 10-Q ↗ | Q1 FY2022 Apr 30, 2021 10-Q ↗ | Q4 FY2021 Apr 30, 2021 10-K ↗ | Q4 FY2020 Apr 30, 2020 10-K ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q4 FY2018 Mar 31, 2018 10-K ↗ | Q4 FY2017 Mar 31, 2017 10-K ↗ | Q4 FY2016 Mar 31, 2016 10-K ↗ | Q4 FY2015 Mar 31, 2015 10-K ↗ | Q4 FY2014 Mar 31, 2014 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LT Debt (USD) | $564.47M | $571.84M | $555.03M | $518.62M | $455.71M | $546.56M | $341.04M | $395.38M | $398.35M | $413.50M | $409.67M | $376.16M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total Equity (USD) | $668.23M | $595.41M | $535.84M | $485.30M | $499.08M | $490.05M | $458.38M | $477.38M | $492.71M | $459.94M | $475.67M | $436.44M | $439.74M | $449.19M | $442.47M | $446.41M | $445.83M | $440.59M | $440.70M | $382.36M | $382.36M | $369.03M | — | — | — | — | — | — |
| Metric | Q4 FY2026 Mar 31, 2026 10-K ↗ | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-K ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-K ↗ | Q3 FY2024 Dec 31, 2023 10-Q ↗ | Q2 FY2024 Sep 30, 2023 10-Q ↗ | Q1 FY2024 Jun 30, 2023 10-Q ↗ | Q4 FY2023 Mar 31, 2023 10-K ↗ | Q3 FY2023 Dec 31, 2022 10-Q ↗ | Q2 FY2023 Sep 30, 2022 10-Q ↗ | Q1 FY2023 Jun 30, 2022 10-Q ↗ | Q4 FY2022 Mar 31, 2022 10-K ↗ | Q3 FY2022 Dec 31, 2021 10-Q ↗ | Q2 FY2022 Sep 30, 2021 10-Q ↗ | Q1 FY2022 Apr 30, 2021 10-Q ↗ | Q4 FY2021 Apr 30, 2021 10-K ↗ | Q4 FY2020 Apr 30, 2020 10-K ↗ | Q4 FY2019 Mar 31, 2019 10-K ↗ | Q4 FY2018 Mar 31, 2018 10-K ↗ | Q4 FY2017 Mar 31, 2017 10-K ↗ | Q4 FY2016 Mar 31, 2016 10-K ↗ | Q4 FY2015 Mar 31, 2015 10-K ↗ | Q4 FY2014 Mar 31, 2014 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $82.37M | $65.90M | $28.71M | $7.77M | $17.87M | $38.49M | $15.48M | $-6.53M | — | $6.58M | $47.36M | $8.79M | $4.66M | $15.78M | $3.08M | $12.04M | $16.70M | $10.35M | $28.14M | — | — | — | — | — | — | — | — | — |
| Operating Cash Flow (USD) | $16.82M | $-7.59M | $-60.66M | $-50.18M | $112.68M | — | — | $12.32M | — | — | — | $-36.45M | $8.90M | $-3.96M | $-50.76M | $41.31M | $-2.69M | $45.58M | — | — | — | — | — | — | — | — | — | — |
Secondary lens
Benchmark Lens
Compare GAIN against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare GAIN against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for GAIN
Return on Common Equity (%) is in the top quartile
No bearish signals detected
Percentile Rankings
How GAIN compares to all companies
Compare GAIN with peers
Stack GAIN against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 13 years · 28 quarters